Pure Global

Anti-SARS CoV-2-IgG Antibody Detection ELISA - India CDSCO Medical Device Registration

Anti-SARS CoV-2-IgG Antibody Detection ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000057_1b9c53791c68e3bc5af031f6a2bfe155_1b8611ea1f783cb9fa4f7f97dbd46e58. This device is marketed under the brand name ZyDx Anti-SARS CoV-2-IgG Antibody Detection ELISA. The license holder is Cadila Healthcare Limited, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Anti-SARS CoV-2-IgG Antibody Detection ELISA
UID: MFG/IVD/2020/000057_1b9c53791c68e3bc5af031f6a2bfe155_1b8611ea1f783cb9fa4f7f97dbd46e58

Brand Name

ZyDx Anti-SARS CoV-2-IgG Antibody Detection ELISA

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

Anti-SARS CoV-2-IgG Antibody Detection ELISA is an in vitro diagnostic kit for the detection of Anti-SARS CoV-2 (ZyDx Anti-SARS CoV-2-IgG Antibody Detection ELISA) Virus infection in human serum/plasma samples

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing